Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy

Prostate

Volumn 72, Issue 11, 2012, Pages 1179-1186

  Sinnott, Michael ^a   Falzarano, Sara M ^a,b   Hernandez, Adrian V ^a   Jones, J Stephen ^a   Klein, Eric A ^a   Zhou, Ming ^a   Magi Galluzzi, Cristina ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

ablation techniques; needle biopsy; prostate cancer; prostatectomy; tumor burden

Indexed keywords

ARTICLE; CANCER FOCI; CANCER LOCALIZATION; CANCER STAGING; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRECANCER AND CANCER-IN-SITU; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR BIOPSY; TUMOR VOLUME;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84862846913     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22467     Document Type: Article

References (32)

1. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H,. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 2004; 171 (3): 1066-1070.
2. Morris AD, Morris RD, Wilson JF, White J, Steinberg S, Okunieff P, Arriagada R, Le MG, Blichert-Toft M, van Dongen JA,. Breast-conserving therapy vs mastectomy in early-stage breast cancer: A meta-analysis of 10-year survival. Cancer J Sci Am 1997; 3 (1): 6-12.
3. Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M,. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007; 4 (11): 632-642.
4. Jones JS,. Focal or subtotal therapy for early stage prostate cancer. Curr Treat Options Oncol 2007; 8 (3): 165-172.
5. Abdollah F, Scattoni V, Raber M, Roscigno M, Briganti A, Suardi N, Gallina A, Capitanio U, Freschi M, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F,. The role of transrectal saturation biopsy in tumour localization: Pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy. BJU Int 2011; 108 (3): 366-371.
6. Quann P, Jarrard DF, Huang W,. Current prostate biopsy protocols cannot reliably identify patients for focal therapy: Correlation of low-risk prostate cancer on biopsy with radical prostatectomy findings. Int J Clin Exp Pathol 2010; 3 (4): 401-407.
7. Falzarano SM, Zhou M, Hernandez AV, Moussa AS, Jones JS, Magi-Galluzzi C,. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: A correlative study and implications for focal therapy. Urology 2010; 76 (3): 682-687.
8. Scales CD Jr, Presti JC Jr, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ,. Predicting unilateral prostate cancer based on biopsy features: Implications for focal ablative therapy-Results from the SEARCH database. J Urol 2007; 178 (4 Pt 1): 1249-1252.
9. Frota R, Stein RJ, Turna B, Kamoi K, Lin YC, Magi-Galluzzi C, Aron M, Gill IS,. Are prostate needle biopsies predictive of the laterality of significant cancer and positive surgical margins? BJU Int 2009; 104 (11): 1599-1603.
10. Tsivian M, Kimura M, Sun L, Mouraviev V, Mayes JM, Polascik TJ,. Predicting unilateral prostate cancer on routine diagnostic biopsy: Sextant vs extended. BJU Int 2009; 105 (8): 1089-1092.
11. Tareen B,. Can MRI improve the predictive ability of biopsy in selecting men for unilateral hemiablative focal therapy? J Urol 2009; 181(suppl): 175-176.
12. Falzarano SM, Navas M, Simmerman K, Klein EA, Rubin MA, Zhou M, Magi-Galluzzi C,. ERG rearrangement is present in a subset of transition zone prostatic tumors. Mod Pathol 2010; 23 (11): 1499-1506.
13. Wise AM, Stamey TA, McNeal JE, Clayton JL,. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60 (2): 264-269.
14. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL,. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29 (9): 1228-1242.
15. Chen ME, Johnston D, Reyes AO, Soto CP, Babaian RJ, Troncoso P,. A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 2003; 27 (10): 1291-1301.
16. Catalona WJ, Smith DS, Ratliff TL, Basler JW,. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993; 270 (8): 948-954.
17. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Spangberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlen BJ, Johansson JE,. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352 (19): 1977-1984.
18. Welch HG, Albertsen PC,. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101 (19): 1325-1329.
19. Nguyen CT, Jones JS,. Focal therapy in the management of localized prostate cancer. BJU Int 2011; 107 (9): 1362-1368.
20. Tareen B, Godoy G, Taneja SS,. Focal therapy: A new paradigm for the treatment of prostate cancer. Rev Urol 2009; 11 (4): 203-212.
21. Tsivian M, Moreira DM, Sun L, Mouraviev V, Kimura M, Moul JW, Polascik TJ,. Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight. Urol Oncol 2010 [Epub ahead of print].
22. Connolly SS, O'Malley KJ, O'Brien A, Kelly DG, Mulvin DW, Quinlan DM,. Can prostate biopsies predict suitability for nerve-sparing radical prostatectomy? Scand J Urol Nephrol 2004; 38 (3): 216-220.
23. Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ,. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110 (4): 906-910.
24. Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS,. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int 2009; 104 (2): 195-199.
25. Iczkowski KA, Hossain D, Torkko KC, Qian J, Lucia MS, Wheeler TM, Rewcastle JC, Bostwick DG,. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urology 2008; 71 (6): 1166-1171.
26. Tareen B, Sankin A, Godoy G, Temkin S, Lepor H, Taneja SS,. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort. Urology 2009; 73 (2): 351-354 (discussion 354-355).
27. Isbarn H, Karakiewicz PI, Vogel S, Jeldres C, Lughezzani G, Briganti A, Montorsi F, Perrotte P, Ahyai SA, Budaus L, Eichelberg C, Heuer R, Kollermann J, Sauter G, Schlomm T, Steuber T, Haese A, Zacharias M, Fisch M, Heinzer H, Huland H, Chun FK, Graefen M,. Unilateral prostate cancer cannot be accurately predicted in low-risk patients. Int J Radiat Oncol Biol Phys 2010; 77 (3): 784-787.
28. Yoon GS, Wang WL, Osunkoya AO, Lane Z, Partin AW, Epstein JI,. Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urology 2008; 179 (6): 2203-2206.
29. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M,. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60 (2 Suppl 1): 3-11.
30. Eggener S, Salomon G, Scardino PT, De la Rosette J, Polascik TJ, Brewster S,. Focal therapy for prostate cancer: Possibilities and limitations. Eur Urol 2010; 58 (1): 57-64.
31. Jeong IG, Kim JK, Cho KS, You D, Song C, Hong JH, Ahn H, Kim CS,. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: Predictive accuracy of laterality and implications for hemi-ablative therapy. J Urol 2010; 184 (5): 1963-1969.
32. Lindner U, Lawrentschuk N, Trachtenberg J,. Image guidance for focal therapy of prostate cancer. World J Urol 2010; 28 (6): 727-734.